Nuvectis Pharma, Inc. Convertible Preferred Stock, Shares Issued upon Conversion
Nuvectis Pharma, Inc. (NVCT) had Convertible Preferred Stock, Shares Issued upon Conversion of 5.01 million shares as of 2022-02-08, per its 10-K filed 2023-03-08.
Discontinued › Notes › Stockholders' Equity Note › Features of Convertible Preferred Stock
us-gaap:ConvertiblePreferredStockSharesIssuedUponConversion · last filed 2023-03-08
- 2022-02-08: Convertible Preferred Stock, Shares Issued upon Conversion 5.01M shares.
| Period end | Convertible Preferred Stock, Shares Issued upon Conversion |
|---|---|
| 2022-02-08 | 5.01M shares 10-K · filed 2023-03-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Verastem, Inc. (VSTM) | United States | $0.706B | -1.71 |
| IRONWOOD PHARMACEUTICALS INC (IRWD) | United States | $0.694B | 5.37 |
| Climb Bio, Inc. (CLYM) | United States | $0.683B | -13.03 |
| COLLEGIUM PHARMACEUTICAL, INC (COLL) | United States | $0.737B | 24.57 |
| ZEVRA THERAPEUTICS, INC. (ZVRA) | United States | $0.668B | 14.61 |
| Faeth Therapeutics, Inc. (FTH) | United States | $0.750B | |
| BlossomHill Therapeutics, Inc. (BLSM) | United States | $0.647B | |
| Design Therapeutics, Inc. (DSGN) | United States | $0.766B | -12.78 |
| Shattuck Labs, Inc. (STTK) | United States | $0.634B | -13.30 |
| Wave Life Sciences, Inc. (WVE) | $0.780B | -5.56 |